Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Neoplasms | 21 | 2023 | 2228 | 4.630 |
Why?
|
| Thyroid Nodule | 7 | 2023 | 745 | 2.460 |
Why?
|
| Adenoma, Oxyphilic | 3 | 2022 | 134 | 2.140 |
Why?
|
| Adenocarcinoma, Follicular | 5 | 2023 | 317 | 1.900 |
Why?
|
| Carcinoma, Papillary | 5 | 2023 | 782 | 1.480 |
Why?
|
| Cytodiagnosis | 4 | 2022 | 425 | 1.410 |
Why?
|
| Thyroid Gland | 4 | 2022 | 1164 | 1.310 |
Why?
|
| Oxyphil Cells | 2 | 2022 | 57 | 0.920 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2020 | 62 | 0.750 |
Why?
|
| Receptors, Steroid | 1 | 2020 | 157 | 0.730 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2020 | 204 | 0.720 |
Why?
|
| Biopsy, Fine-Needle | 7 | 2023 | 1073 | 0.690 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2020 | 293 | 0.590 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2022 | 320 | 0.590 |
Why?
|
| DNA Mismatch Repair | 1 | 2019 | 427 | 0.550 |
Why?
|
| In Situ Hybridization | 1 | 2019 | 1962 | 0.530 |
Why?
|
| Parathyroid Diseases | 1 | 2014 | 49 | 0.510 |
Why?
|
| Microscopy, Polarization | 1 | 2014 | 88 | 0.500 |
Why?
|
| Calcium Oxalate | 1 | 2014 | 71 | 0.490 |
Why?
|
| Frozen Sections | 1 | 2014 | 155 | 0.480 |
Why?
|
| Thyroidectomy | 4 | 2020 | 877 | 0.470 |
Why?
|
| Parathyroid Glands | 1 | 2014 | 509 | 0.440 |
Why?
|
| Head and Neck Neoplasms | 3 | 2022 | 2670 | 0.430 |
Why?
|
| Neoplasm Invasiveness | 4 | 2022 | 3600 | 0.410 |
Why?
|
| Papillomavirus Infections | 2 | 2022 | 1519 | 0.410 |
Why?
|
| Thyroid Diseases | 1 | 2014 | 379 | 0.390 |
Why?
|
| RNA, Viral | 1 | 2019 | 2892 | 0.390 |
Why?
|
| Aged, 80 and over | 14 | 2022 | 57641 | 0.320 |
Why?
|
| World Health Organization | 2 | 2022 | 1302 | 0.260 |
Why?
|
| Aged | 18 | 2022 | 161448 | 0.250 |
Why?
|
| Immunohistochemistry | 4 | 2020 | 11490 | 0.230 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9716 | 0.220 |
Why?
|
| Middle Aged | 18 | 2022 | 212226 | 0.220 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2023 | 2006 | 0.220 |
Why?
|
| Neoplasm Staging | 3 | 2021 | 10927 | 0.200 |
Why?
|
| Mitotic Index | 1 | 2021 | 173 | 0.190 |
Why?
|
| Adult | 15 | 2021 | 211660 | 0.190 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2020 | 92 | 0.180 |
Why?
|
| Necrosis | 2 | 2022 | 1623 | 0.180 |
Why?
|
| Carcinoma, Ductal | 1 | 2020 | 104 | 0.180 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2020 | 77 | 0.180 |
Why?
|
| Cytological Techniques | 1 | 2021 | 221 | 0.180 |
Why?
|
| Breath Tests | 1 | 2020 | 275 | 0.180 |
Why?
|
| Humans | 28 | 2023 | 725419 | 0.180 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 215 | 0.170 |
Why?
|
| Smoke | 1 | 2020 | 222 | 0.170 |
Why?
|
| Young Adult | 7 | 2020 | 55846 | 0.170 |
Why?
|
| Carcinoma | 2 | 2023 | 2336 | 0.170 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2019 | 202 | 0.170 |
Why?
|
| Male | 17 | 2021 | 347092 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2021 | 659 | 0.160 |
Why?
|
| Cohort Studies | 6 | 2020 | 39913 | 0.160 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2020 | 258 | 0.160 |
Why?
|
| Gene Fusion | 1 | 2021 | 374 | 0.160 |
Why?
|
| Female | 17 | 2021 | 375593 | 0.160 |
Why?
|
| Carbon Monoxide | 1 | 2020 | 521 | 0.150 |
Why?
|
| Papillomaviridae | 2 | 2022 | 1105 | 0.150 |
Why?
|
| Prognosis | 5 | 2023 | 28727 | 0.150 |
Why?
|
| DNA, Viral | 2 | 2022 | 2271 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 719 | 0.140 |
Why?
|
| Pathology, Molecular | 1 | 2019 | 337 | 0.140 |
Why?
|
| Birefringence | 1 | 2014 | 57 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 14716 | 0.130 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 12945 | 0.120 |
Why?
|
| Crystallization | 1 | 2014 | 518 | 0.120 |
Why?
|
| Disease-Free Survival | 2 | 2021 | 6885 | 0.120 |
Why?
|
| Retrospective Studies | 8 | 2023 | 74196 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 14963 | 0.100 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 2617 | 0.100 |
Why?
|
| Intraoperative Care | 1 | 2014 | 760 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 6533 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 4887 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2019 | 4943 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3430 | 0.090 |
Why?
|
| Adolescent | 4 | 2020 | 84518 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 3948 | 0.070 |
Why?
|
| Adenoma | 1 | 2017 | 2166 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2023 | 6353 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 19626 | 0.070 |
Why?
|
| Smoking | 1 | 2020 | 8886 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 9375 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 8897 | 0.060 |
Why?
|
| Phenotype | 1 | 2020 | 16264 | 0.060 |
Why?
|
| Mutation | 3 | 2023 | 29654 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2019 | 23183 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11304 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 627 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2021 | 61705 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2021 | 1251 | 0.030 |
Why?
|
| Child | 1 | 2020 | 75273 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 1892 | 0.020 |
Why?
|
| Animals | 1 | 2020 | 168715 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2150 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2022 | 21583 | 0.020 |
Why?
|
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_